Clinical Trial Update: Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 results update on a delayed-release pancrelipase for pancreatic exocrine insufficiency in cystic fibrosis; the study has completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pancreatic Exocrine Insufficiency

Drugs mentioned

• Pancrelipase, delayed-release (pancrelipase)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Cystic Fibrosis, Pancreatic Exocrine Insufficiency | Phase 3 | Status: COMPLETED | Results posted: 2010-10-01